CAM
ARRY

Capstone Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Capstone Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,687
Closed -$66K – 1990
2013
Q3 		$66K Hold
10,687
– – ﹤0.01% 1971
2013
Q2 		$49K Buy
+10,687
New +$57.5K ﹤0.01% 1934

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capstone Asset Management's ARRY Position: Q4 2013 in Review

Capstone Asset Management sold out of Array Biopharma Inc (ARRY) in Q4 2013, closing a stake of 10,687 shares — an estimated $66K sold.

Capstone Asset Management first reported a position in ARRY in Q2 2013 and held it in 2 quarters. The position peaked at $66K in Q3 2013. 143 funds tracked by Wall St. Rank hold ARRY as of Q4 2013.

  • Capstone Asset Management reported no remaining Array Biopharma Inc position as of Q4 2013 after selling out during the quarter.
  • Capstone Asset Management sold 10,687 Array Biopharma Inc shares in Q4 2013, an estimated $66K.
  • Capstone Asset Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 2 quarters.
  • Capstone Asset Management's Array Biopharma Inc position peaked at $66K in Q3 2013.
  • 143 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2013.

Based on Capstone Asset Management's 13F filing for Q4 2013, filed 4 Feb 2014.